DoubleBlind Revenue

About DoubleBlind

DoubleBlind is a biannual print magazine and digital media company covering timely, untold stories about psychedelics and all they intersect with, from mental health to environmental justice. We listen to everyone, from the indigenous communities, who have preserved these medicines for millennia, to the people in our society who most need healing, but don’t have access to it. And we go everywhere, from the Ayahuasca tourism industry in Peru to laboratories at leading universities. We're not speaking to the veteran tripper nor evangelizing to the anti-drug square. We are speaking to everyone who is curious about psychedelics. And we are speaking to anyone craving fresh perspectives on some of the most important issues of our time: the depression epidemic, the corporatization of medicine, and the aching that people around the globe feel for spirituality or some other collective sense of meaning. Together, we dive deep below the surface of the daily news cycle through long-form reported features, poetry, visual art, and provocative photo essays offered both online and in-print. The conversation doesn't end there. Psychedelics—as the first class of drugs that heal through inspiring mystical experiences—hold the potential to shift how the Western medical community perceives wellness more broadly. We cover that too. With an open mind and a commitment to fact-checking, we provide nuance to the reporting on alternative healing modalities and mindfulness movements. Psychedelics aren’t just about the 1960s cultural revolution—or the research renaissance that has followed it in recent decades. They’re about what it means to be well as individuals and a collective: we invite you to contemplate that with us.

View contact profiles from DoubleBlind